CEIClass II
Uranyl Acetate/Zinc Acetate, Sodium
21 CFR 862.1665 / Clinical Chemistry
CEI is the FDA product code for Uranyl Acetate/Zinc Acetate, Sodium, a class II device type, regulated under 21 CFR 862.1665. As of , FDA records hold 4 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- CEI
- Device name
- Uranyl Acetate/Zinc Acetate, Sodium
- Regulation
- 21 CFR 862.1665
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 4
- Ingested recalls
- 0
Clearances, product code CEI
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1983 | 1 |
| 1990 | 1 |
| 1991 | 1 |
| 2005 | 1 |
Applicants with the most clearances
Product code CEI| Applicant | Clearances |
|---|---|
| Mallinckrodt Critical Care | 1 |
| Randox Laboratories, Limited | 1 |
| Sterling Diagnostics, Inc. | 1 |
| Tech Intl. Co. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
